
Ivalp 750mg Tablet XR
Marketer
Kivi Labs Ltd
Salt Composition
Valproic Acid (750mg)
Overview Ivalp 750mg Tablet XR
Extended-release Ivalp 750mg tablets are indicated for managing epilepsy (seizures) and bipolar disorder, and also for migraine prophylaxis. Their mechanism involves calming brain activity through nerve relaxation. Ivalp 750mg XR tablets can be ingested with or without food, ideally at the same time daily, as directed by your physician. Missed doses should be taken promptly upon recall. Complete the prescribed course, even with symptom improvement; discontinuation should only occur under medical supervision to avoid potential seizure exacerbation. Commonly reported adverse effects include headache, blurred vision, anorexia, nausea, emesis, alopecia, and diarrhea. Drowsiness and dizziness are possible; avoid activities demanding alertness until the drug's effects are known. Weight gain is a potential side effect, mitigable through balanced nutrition and exercise. Consult your doctor concerning any persistent or bothersome side effects.
Uses of Ivalp 750mg Tablet XR
Management of epilepsy and seizures | Migraine prophylaxis | Bipolar disorder treatment
Major Benefits of Ivalp 750mg Tablet XR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ivalp 750mg Tablet XR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with food.
Common Side effects of Ivalp 750mg Tablet XR:
- Headache
- Dizziness
- Blurred vision
- Loss of appetite
- Nausea
- Vomiting
- Sleepiness
- Hair loss
- Weight gain
- Tremors
- Double vision
- Diarrhea
- Impaired coordination
- Increased appetite
- Weakness
- Stomach pain
How to use Ivalp 750mg Tablet XR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Ivalp 750mg Extended-Release tablet should be taken with a meal.
How Ivalp 750mg Tablet XR works:
Extended-release Ivalp 750mg tablets are used to treat epilepsy. They work by reducing the overactive electrical signaling in brain neurons, thus managing seizures.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Ivalp 750mg extended-release tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Ivalp 750mg tablets pose a confirmed risk to a fetus; therefore, their use during pregnancy is contraindicated. In exceptional, life-threatening circumstances where the potential benefits outweigh the known hazards, a physician may prescribe them. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Ivalp 750mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
Extended-release Ivalp 750mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Extended-release Ivalp 750mg tablets require careful administration in individuals with impaired renal function. Dosage modification of Ivalp 750mg extended-release tablets may be necessary. Physician consultation is advised. Kidney disease should be disclosed to your physician.
LiverUNSAFE
Extended-release Ivalp 750mg tablets are contraindicated in individuals with hepatic impairment; their use should be strictly avoided. Patients with severe or active liver disease should not take this medication and should seek medical advice.
What if you forget to take Ivalp 750mg Tablet XR :
Should you forget to take your Ivalp 750mg Extended-Release tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ivalp 750mg Tablet XR
| Label | Value |
|---|---|
| Chemical Category | Valproate |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Anticonvulsant sodium channel blockers |
